Fort Washington Investment Advisors Inc Reata Pharmaceuticals Inc Transaction History

Fort Washington Investment Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$93.53 - $163.34 $168,354 - $294,012	-1,800 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$74.57 - $217.92 $134,226 - $392,256	1,800 New	1,800 $368,000
Q1 2019 May 10, 2019	SELL	$51.9 - $101.79 $337,869 - $662,652	-6,510 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$48.76 - $76.44 $85,086 - $133,387	1,745 Added 36.62%	6,510 $365,000
Q3 2018 Nov 07, 2018	BUY	$35.64 - $92.06 $169,824 - $438,665	4,765 New	4,765 $390,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.